Stay updated with breaking news from Embecta Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Presenter SpeechCaroline Borowski Hi all. My name is Caroline Borowski, and I'm part of the healthcare investment banking group here at JPMorgan. It is my pleasure to introduce Dev Kurdikar, the CEO;...
PARSIPPANY, N.J., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") EMBC, a global diabetes care company with a 100-year legacy in insulin delivery,…
Pen Needles Market Market Growth 2024 To 2032:The growth of the global pen needles market is driven by multiple factors, including an increase in the prevalence of chronic conditions, a surge in awareness and adoption of injector pens, and advantages offered by pen needles over traditional syringes. The rising preva...
Embecta (NASDAQ:EMBC – Get Free Report) and Teleflex (NYSE:TFX – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, analyst recommendations, dividends, earnings and profitability. Earnings & Valuation This table compares Embecta and Teleflex’s top-line […]
Embecta Corp. (NASDAQ:EMBC – Get Free Report) was the target of a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 3,330,000 shares, an increase of 6.7% from the October 31st total of 3,120,000 shares. Currently, 5.9% of the shares of the company are short […]